Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca⁺⁺ trial.
Roberts D, Niazi K, Miller W, Krishnan P, Gammon R, Schreiber T, Shammas NW, Clair D; DEFINITIVE Ca⁺⁺ Investigators. Roberts D, et al. Among authors: niazi k. Catheter Cardiovasc Interv. 2014 Aug 1;84(2):236-44. doi: 10.1002/ccd.25384. Epub 2014 Feb 5. Catheter Cardiovasc Interv. 2014. PMID: 24402764 Free PMC article. Clinical Trial.
Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study).
Shishehbor MH, Zeller T, Werner M, Brodmann M, Parise H, Holden A, Lichtenberg M, Parikh SA, Kashyap VS, Pietras C, Tirziu D, Ardakani S, Beschorner U, Krishnan P, Niazi KA, Wali AU, Lansky AJ. Shishehbor MH, et al. Among authors: niazi ka. Circulation. 2022 May 31;145(22):1645-1654. doi: 10.1161/CIRCULATIONAHA.122.059646. Epub 2022 Apr 4. Circulation. 2022. PMID: 35377157 Clinical Trial.
Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
Krishnan P, Faries P, Niazi K, Jain A, Sachar R, Bachinsky WB, Cardenas J, Werner M, Brodmann M, Mustapha JA, Mena-Hurtado C, Jaff MR, Holden AH, Lyden SP. Krishnan P, et al. Among authors: niazi k. Circulation. 2017 Sep 19;136(12):1102-1113. doi: 10.1161/CIRCULATIONAHA.117.028893. Epub 2017 Jul 20. Circulation. 2017. PMID: 28729250 Free PMC article. Clinical Trial.
Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry.
Banerjee S, Jeon-Slaughter H, Armstrong EJ, Bajzer C, Abu-Fadel M, Khalili H, Prasad A, Bou Dargham B, Kamath P, Addo T, Luna M, Gigliotti O, Foteh M, Cawich I, Kinlay S, Ali M, Ramanan B, Niazi K, Tsai S, Shammas NW, Brilakis ES. Banerjee S, et al. Among authors: niazi k. J Invasive Cardiol. 2019 Jan;31(1):1-9. J Invasive Cardiol. 2019. PMID: 30611122 Free PMC article.
Clinical outcomes of patients with and without chronic kidney disease undergoing endovascular revascularization of infrainguinal peripheral artery disease: Insights from the XLPAD registry.
Kabir R, Vuppala S, Liu Y, Tejani I, Weideman R, Banerjee A, Tsai S, Huffman L, Niazi K, Brilakis ES, Shishehbor MH, Banerjee S. Kabir R, et al. Among authors: niazi k. Catheter Cardiovasc Interv. 2021 Aug 1;98(2):310-316. doi: 10.1002/ccd.29491. Epub 2021 Feb 1. Catheter Cardiovasc Interv. 2021. PMID: 33527684
87 results